Insider Selling: Fluidigm Co. (NASDAQ:FLDM) Insider Sells 11,545 Shares of Stock

Fluidigm Co. (NASDAQ:FLDM) insider Levin Easterly Partners Llc sold 11,545 shares of the business’s stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $5.55, for a total value of $64,074.75. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Levin Easterly Partners Llc also recently made the following trade(s):

  • On Tuesday, August 13th, Levin Easterly Partners Llc sold 151,011 shares of Fluidigm stock. The stock was sold at an average price of $7.01, for a total value of $1,058,587.11.
  • On Wednesday, August 7th, Levin Easterly Partners Llc sold 129,237 shares of Fluidigm stock. The shares were sold at an average price of $6.90, for a total value of $891,735.30.
  • On Thursday, August 1st, Levin Easterly Partners Llc sold 1,629 shares of Fluidigm stock. The shares were sold at an average price of $12.25, for a total value of $19,955.25.
  • On Monday, July 29th, Levin Easterly Partners Llc sold 82,585 shares of Fluidigm stock. The shares were sold at an average price of $11.97, for a total value of $988,542.45.
  • On Friday, July 26th, Levin Easterly Partners Llc sold 195,982 shares of Fluidigm stock. The shares were sold at an average price of $11.92, for a total value of $2,336,105.44.
  • On Wednesday, July 24th, Levin Easterly Partners Llc sold 28,090 shares of Fluidigm stock. The shares were sold at an average price of $11.78, for a total value of $330,900.20.
  • On Monday, July 22nd, Levin Easterly Partners Llc sold 61,432 shares of Fluidigm stock. The shares were sold at an average price of $11.57, for a total value of $710,768.24.
  • On Friday, July 19th, Levin Easterly Partners Llc sold 83,728 shares of Fluidigm stock. The shares were sold at an average price of $11.50, for a total value of $962,872.00.
  • On Wednesday, July 17th, Levin Easterly Partners Llc sold 134,487 shares of Fluidigm stock. The shares were sold at an average price of $11.32, for a total value of $1,522,392.84.
  • On Friday, June 28th, Levin Easterly Partners Llc sold 157,349 shares of Fluidigm stock. The shares were sold at an average price of $12.30, for a total value of $1,935,392.70.

FLDM stock traded down $0.06 during mid-day trading on Friday, hitting $5.38. The stock had a trading volume of 369,357 shares, compared to its average volume of 889,495. The company has a current ratio of 2.86, a quick ratio of 2.48 and a debt-to-equity ratio of 0.32. Fluidigm Co. has a 1-year low of $5.06 and a 1-year high of $14.90. The company has a fifty day moving average of $7.18 and a 200 day moving average of $11.14. The stock has a market capitalization of $380.31 million, a price-to-earnings ratio of -6.73 and a beta of 2.37.

Fluidigm (NASDAQ:FLDM) last issued its earnings results on Thursday, August 1st. The medical research company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.08). Fluidigm had a negative return on equity of 31.45% and a negative net margin of 57.48%. The firm had revenue of $28.20 million during the quarter, compared to analyst estimates of $30.16 million. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts expect that Fluidigm Co. will post -0.55 earnings per share for the current fiscal year.

Hedge funds have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in Fluidigm in the 2nd quarter worth about $68,000. BNP Paribas Arbitrage SA increased its position in Fluidigm by 3,543.1% in the 1st quarter. BNP Paribas Arbitrage SA now owns 6,849 shares of the medical research company’s stock worth $91,000 after purchasing an additional 6,661 shares during the last quarter. Aperio Group LLC acquired a new position in Fluidigm in the 2nd quarter worth about $124,000. Bank of America Corp DE increased its position in Fluidigm by 149.3% in the 4th quarter. Bank of America Corp DE now owns 14,449 shares of the medical research company’s stock worth $125,000 after purchasing an additional 8,654 shares during the last quarter. Finally, SMH Capital Advisors Inc. acquired a new position in Fluidigm in the 1st quarter worth about $146,000.

Several research analysts recently weighed in on the company. BidaskClub lowered Fluidigm from a “hold” rating to a “sell” rating in a research report on Friday, August 16th. Zacks Investment Research raised Fluidigm from a “hold” rating to a “buy” rating and set a $14.00 price target on the stock in a research report on Wednesday, July 3rd. Finally, ValuEngine lowered Fluidigm from a “buy” rating to a “hold” rating in a research report on Wednesday, June 12th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $14.75.

About Fluidigm

Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow.

Recommended Story: How dollar cost averaging works

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.